Kite Presents Promising Preclinical Data from KITE-585, a Fully … – Business Wire (press release)
|
Kite Presents Promising Preclinical Data from KITE-585, a Fully …
Business Wire (press release) Kite Pharma, Inc. (Nasdaq:KITE) today announced new data presentations from preclinical studies related to KITE-585, a fully human anti-B cell maturat. |
